As a result, the muscles become weak when a person performs repeated physical movements. The disease is neither contagious nor inherited but it is often misunderstood as a psychological issue or ...

Dianthus Therapeutics targets severe autoimmune diseases with DNTH103. Read more on DNTH's promise amid competitive ...

argenx also highlighted its commitment to reach the broader MG patient community with two ongoing label expansion studies in ocular myasthenia ... on transitioning from IVIg to VYVGART Hytrulo ...

Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia ... be used concomitantly with intravenous immunoglobulin and plasma exchange ...

Amsterdam, the Netherlands Thursday, April 10, 2025, 18:00 Hrs [IST] ...

Currently widely used intravenous immunoglobulin and plasma exchange therapy remains ineffective in some patients and is limited by multiple contraindications. Efgartigimod is a newly approved FcRn ...

My name is Tasha White, and I was diagnosed with myasthenia gravis at the young age of six years ... Suddenly, I was in the hospital, being introduced to new treatments like IVIG and plasmapheresis to ...

Conclusion: Compared to normal patients, MG patients are prone to developing severe COVID-19 infection, which is associated with the daily corticosteroid dose and the frequency of myasthenia ...

Myasthenia Gravis Foundation of America (MGFA ... plasmapheresis, plasma exchange, or intravenous immunoglobulin to control symptoms despite treatment with steroids and NSISTs; or * one of the ...